Industry

MET is the most common biomarker in patients with EGFR-mutated lung cancer who develop resistance to targeted therapy Global SAFFRON Phase III trial evaluating this combination is underway WILMINGTON, Del.–(BUSINESS WIRE)–Preliminary results from the SAVANNAH Phase II trial showed that TAGRISSO® (osimertinib) plus savolitinib demonstrated an objective response rate (ORR) of 49% (95% confidence interval … [Read more…]

Company Receives FDA Clearance of ALLY™ Adaptive Cataract Treatment System Second Quarter Procedure Volume Increases 8%, in the Aggregate, and 15% in the U.S. Over Q2 2021 Levels ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, … [Read more…]

EL DORADO HILLS, Calif.–(BUSINESS WIRE)–#O2Investment–Frontier Dental Lab Group (“Frontier” or “FDL Group”) (www.frontierdentallabgroup.com), a leading dental laboratory platform, announced today that it has partnered with and made an investment in D&S Dental Laboratory, Inc. (“D&S”) (https://dnsdental.com/), a full-service dental laboratory based in Waunakee, WI. Brent West, President of FDL Group, commented, “D&S has an extremely … [Read more…]

POTOMAC, Md.–(BUSINESS WIRE)–#IGC–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announces its financial results for the three months ended June 30, 2022, which is the first quarter of the Company’s 2023 fiscal year. The highlights for the quarter are: The Company has submitted a protocol to the U.S. Food and Drug Administration … [Read more…]

The Company identifies critical milestones required to commence clinical trial programme LONDON–(BUSINESS WIRE)–SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce that is has a date for a scientific advice meeting with the UK Medicines and Healthcare products Regulatory Agency (MHRA) to discuss its human clinical trial programme. SpectrumX has confirmed the scientific … [Read more…]

Research also shows that cohort will turn to tech to battle loneliness and find support, disrupting common perception that it’s a negative influence on youth mental health REDWOOD CITY, Calif.–(BUSINESS WIRE)–New research from Telosity by Vinaj Ventures, the leader in the youth mental health investor space, indicates that school is the top trigger for depression … [Read more…]

VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), one of the largest publicly listed US based ketamine wellness clinics, is pleased to report continued expansion of service lines offering an online vitamin supplement line, an online global curriculum, and an onsite and virtual training program … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “United Kingdom Renal Denervation Market, By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product, By Therapeutic Area, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. United Kingdom renal denervation market may flourish with an impressive CAGR during the forecast period of 2023-2027, … [Read more…]

LUGANO, Switzerland–(BUSINESS WIRE)–Pharma Tech Holding SA (“PTH”) announced today it has secured a CHF 30 million investment to support its portfolio investments from LDA Capital Ltd, a global investment group with expertise in cross border transactions including the agriculture, Agri-tech, and CBD industries. Established in 2019, PTH is a Swiss based holding company, which invests … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well … [Read more…]